. . . . . . . . . . . . "p(HGNC:ERBB2) -> path(SDIS:\"Paclitaxel resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "ErbB2 overexpression confers chemoresistance to certain chemotherapeutic agents such as paclitaxel. trastuzumab can effectively sensitize ErbB2-overexpressing breast cancer cells to paclitaxel" . . "Selventa" . . . . "2014-07-03T14:31:44.632+02:00"^^ . . .